<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rana, Rashmi</style></author><author><style face="normal" font="default" size="100%">Chauhan, Kirti</style></author><author><style face="normal" font="default" size="100%">Gautam, Poonam</style></author><author><style face="normal" font="default" size="100%">Kulkarni, Mahesh</style></author><author><style face="normal" font="default" size="100%">Banarjee, Reema</style></author><author><style face="normal" font="default" size="100%">Chugh, Parul</style></author><author><style face="normal" font="default" size="100%">Chhabra, Satnam Singh</style></author><author><style face="normal" font="default" size="100%">Acharya, Rajesh</style></author><author><style face="normal" font="default" size="100%">Kalra, Samir Kumar</style></author><author><style face="normal" font="default" size="100%">Gupta, Anshul</style></author><author><style face="normal" font="default" size="100%">Jain, Sunila</style></author><author><style face="normal" font="default" size="100%">Ganguly, Nirmal Kumar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Plasma-derived extracellular vesicles reveal galectin-3 binding protein as potential biomarker for early detection of glioma</style></title><secondary-title><style face="normal" font="default" size="100%">Frontiers in Oncology</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">blood-based biomarker</style></keyword><keyword><style  face="normal" font="default" size="100%">early detection</style></keyword><keyword><style  face="normal" font="default" size="100%">galectin-3 binding protein</style></keyword><keyword><style  face="normal" font="default" size="100%">plasma-derived extracellular vesicles</style></keyword><keyword><style  face="normal" font="default" size="100%">proteomics</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">NOV 26</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">778754</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">{Gliomas are the most common type of the malignant brain tumor, which arise from glial cells. They make up about 40% of all primary brain tumors and around 70% of all primary malignant brain tumors. They can occur anywhere in the central nervous system (CNS) and have a poor prognosis. The average survival of glioma patients is approximately 6-15 months with poor aspects of life. In this edge, identification of proteins secreted by cancer cells is of special interest because it may provide a better understanding of tumor progression and provide early diagnosis of the diseases. Extracellular vesicles (EVs) were isolated from pooled plasma of healthy controls (n=03) and patients with different grades of glioma (Grade I or II or III</style></abstract><work-type><style face="normal" font="default" size="100%">Article</style></work-type><custom3><style face="normal" font="default" size="100%">Foreign</style></custom3><custom4><style face="normal" font="default" size="100%">6.244</style></custom4></record></records></xml>